Jump Financial’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$349K Buy
+2,985
New +$300K ﹤0.01% 1613
2026
Q1
Sell
-53,265
Closed -$4.21M 2204
2025
Q4
$4.21M Sell
53,265
-108,835
-67% -$7.81M 0.05% 407
2025
Q3
$11.9M Buy
162,100
+13,411
+9% +$853K 0.14% 181
2025
Q2
$7.57M Buy
148,689
+132,866
+840% +$5.92M 0.08% 305
2025
Q1
$713K Sell
15,823
-21,811
-58% -$1.03M 0.01% 943
2024
Q4
$1.56M Sell
37,634
-9,134
-20% -$381K 0.03% 595
2024
Q3
$1.82M Buy
46,768
+26,290
+128% +$1.05M 0.04% 557
2024
Q2
$700K Buy
+20,478
New +$537K 0.01% 977
2024
Q1
Sell
-8,166
Closed -$241K 2140
2023
Q4
$241K Sell
8,166
-79,218
-91% -$2.4M 0.01% 1458
2023
Q3
$2.76M Buy
87,384
+75,024
+607% +$2.05M 0.1% 262
2023
Q2
$320K Buy
+12,360
New +$329K 0.01% 1269
2023
Q1
Sell
-25,000
Closed -$488K 1867
2022
Q4
$488K Sell
25,000
-4,681
-16% -$92.5K 0.03% 789
2022
Q3
$624K Buy
29,681
+8,481
+40% +$204K 0.02% 804
2022
Q2
$413K Buy
21,200
+100
+0.5% +$2.36K 0.02% 932
2022
Q1
$464K Buy
+21,100
New +$430K 0.02% 851

Other funds holding MIRM

Jump Financial's MIRM Position: Q2 2026 in Review

Jump Financial opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 2,985 shares worth $349K. The stake represents ﹤0.01% of the portfolio and ranks #1613 among its holdings. This is a return to the name: Jump Financial previously reported a position in MIRM as recently as Q4 2025.

Jump Financial first reported a position in MIRM in Q1 2022 and has held it in 15 quarters since. The position peaked at $11.9M in Q3 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Jump Financial held 2,985 shares of Mirum Pharmaceuticals worth $349K as of Q2 2026.
  • Mirum Pharmaceuticals was a new Jump Financial position in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1613 holding.
  • Jump Financial first reported a position in Mirum Pharmaceuticals in Q1 2022 and has held it in 15 quarters since.
  • Jump Financial's Mirum Pharmaceuticals position peaked at $11.9M in Q3 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.